Ouabain-induced changes in electrophysiologic properties of neonatal, young and adult canine cardiac Purkinje Fibers.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 1151753)

Published in J Pharmacol Exp Ther on July 01, 1975

Authors

M R Rosen, A J Hordof, A B Hodess, M Verosky, Y Vulliemoz

Articles by these authors

Pathophysiology and prevention of atrial fibrillation. Circulation (2001) 2.31

Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope (1997) 2.15

Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol (2005) 2.12

Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation (1992) 1.92

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92

Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart. Circ Res (2000) 1.81

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res (2000) 1.70

Altering ventricular activation remodels gap junction distribution in canine heart. J Cardiovasc Electrophysiol (2001) 1.64

Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation (1998) 1.62

Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on Ouabain-induced delayed afterdepolarizations in canine Purkinje fibers. Circ Res (1980) 1.47

Congenital and acquired long QT syndrome. Eur Heart J (2000) 1.45

Effects of mibefradil, a T-type calcium current antagonist, on electrophysiology of Purkinje fibers that survived in the infarcted canine heart. J Cardiovasc Electrophysiol (1999) 1.44

Acute pulmonary embolism in pediatric patients awaiting heart transplantation. J Am Coll Cardiol (1991) 1.43

Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation (1995) 1.42

Modulation of delayed afterdepolarisations by alpha 1 adrenergic receptor subtypes. Cardiovasc Res (1993) 1.42

Long-term electrophysiological effects of regional cardiac sympathetic denervation of the neonatal dog. Cardiovasc Res (2001) 1.40

Premature escape beats induced by overdrive pacing in canine Purkinje fibers. Evidence for the role of normal automaticity as an underlying cellular mechanism. Circulation (1990) 1.39

Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations. Circulation (1996) 1.36

Cyclic AMP and smooth muscle function. Ann N Y Acad Sci (1971) 1.36

The controversial M cell. J Cardiovasc Electrophysiol (1999) 1.32

Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation (1984) 1.31

Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs. Circulation (2001) 1.30

Mechanisms of digitalis toxicity. Effects of ouabain on phase four of canine Purkinje fiber transmembrane potentials. Circulation (1973) 1.27

Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther (1998) 1.25

Effects of phentolamine on electrophysiologic properties of isolated canine purkinje fibers. J Pharmacol Exp Ther (1971) 1.23

Ultrastructure and transmembrane potentials of cardiac muscle in the human anterior mitral valve leaflet. Circulation (1979) 1.21

The effect of extracellular potassium on the intracellular potassium ion activity and transmembrane potentials of beating canine cardiac Purkinje fibers. J Gen Physiol (1977) 1.21

Cellular mechanisms for cardiac arrhythmias. Circ Res (1981) 1.21

Effects of verapamil on electrophysiologic properties of canine cardiac Purkinje fibers. J Pharmacol Exp Ther (1974) 1.20

Pathophysiologic mechanisms of cardiac arrhythmias. Am Heart J (1983) 1.19

Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol (1985) 1.18

Effects of protein kinase inhibitors on canine Purkinje fibre pacemaker depolarization and the pacemaker current i(f). J Physiol (1991) 1.18

Subclassification of beta-adrenergic receptors in cultured rat cardiac myoblasts and fibroblasts. Circ Res (1980) 1.16

Spontaneous complete closure of a congenital coronary artery fistula. J Am Coll Cardiol (1983) 1.12

Transient outward current, Ito1, is altered in cardiac memory. Circulation (1999) 1.11

Cardiac effects of disopyramide. Am Heart J (1976) 1.10

Electrophysiologic properties of isolated preparations of human atrial myocardium. Circ Res (1972) 1.10

Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine. Am Heart J (1975) 1.10

Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation. Circulation (1979) 1.08

Cellular electrophysiology of digitalis toxicity. J Am Coll Cardiol (1985) 1.07

Correlation between effects of ouabain on the canine electrocardiogram and transmembrane potentials of isolated Purkinje fibers. Circulation (1973) 1.05

Cyclic adenosine monophosphate and vascular reactivity in spontaneously hypertensive rats. Biochem Pharmacol (1975) 1.04

Coupling an HCN2-expressing cell to a myocyte creates a two-cell pacing unit. J Physiol (2009) 1.04

Cyclic phosphodiesterase activity and the action of papaverine. Biochem Biophys Res Commun (1970) 1.04

The report of the American Heart Association task force on strategies to increase federal research funding. Circulation (1990) 1.03

Stimulation of cardiac alpha receptors increases Na/K pump current and decreases gK via a pertussis toxin-sensitive pathway. Biophys J (1988) 1.03

Effects of adrenergic amines on electrophysiological properties and automaticity of neonatal and adult canine Purkinje fibers: evidence for alpha- and beta-adrenergic actions. Circ Res (1977) 1.02

Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. Am Heart J (1975) 1.02

Induction and termination of triggered activity by pacing in isolated canine Purkinje fibers. Circulation (1984) 1.01

The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res (1983) 1.01

Effect of alpha adrenergic agonists and blockers on Purkinje fiber transmembrane potentials and automaticity in the dog. J Pharmacol Exp Ther (1984) 1.00

The arrhythmogenic actions of histamine on human atrial fibers. Circ Res (1981) 1.00

Electropharmacology of antiarrhythmic drugs. Am Heart J (1983) 0.99

Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res (1991) 0.99

Evolution and resolution of long-term cardiac memory. Circulation (1998) 0.99

Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I. In vitro study. Circulation (1997) 0.98

Characteristics of initiation and termination of catecholamine-induced triggered activity in atrial fibers of the coronary sinus. Circulation (1986) 0.98

Persistent T-wave changes after alteration of the ventricular activation sequence. New insights into cellular mechanisms of 'cardiac memory'. Circulation (1993) 0.96

Cyclic 3',5'-adenosine monophosphate and bronchial tone. Eur J Pharmacol (1977) 0.96

Can accelerated atrioventricular junctional escape rhythms be explained by delayed afterdepolarizations? Am J Cardiol (1980) 0.96

The cellular electrophysiologic effects of digitalis on human atrial fibers. Circulation (1978) 0.94

A role for the renin-angiotensin system in the evolution of cardiac memory. J Cardiovasc Electrophysiol (1999) 0.94

Ventricular electrophysiological properties: is interspecies variability related to thyroid state? Am J Physiol (1987) 0.93

Does triggered activity have a role in the genesis of cardiac arrhythmias? Ann Intern Med (1981) 0.93

T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Implications with respect to phenomenon of cardiac 'memory'. Circulation (1992) 0.92

Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart. J Cardiovasc Pharmacol (1980) 0.92

Sympathetic innervation modulates ventricular impulse propagation and repolarisation in the immature rat heart. Cardiovasc Res (1993) 0.92

An evaluation of automaticity and triggered activity in the canine heart one to four days after myocardial infarction. Circulation (1985) 0.91

Adenyl cyclase-phosphodiesterase system in arterial smooth muscle. Life Sci I (1972) 0.91

Possible communication between murine macrophages oriented in linear chains in tissue culture. Exp Cell Res (1976) 0.90

Steady-state and nonsteady-state action potentials in fibrillating canine atrium: abnormal rate adaptation and its possible mechanisms. Cardiovasc Res (1999) 0.90

Effects of alpha-adrenergic stimulation on intracellular sodium activity and automaticity in canine Purkinje fibers. Circ Res (1990) 0.90

Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C. Am Heart J (1975) 0.90

Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers. Eur J Pharmacol (1980) 0.90

Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. B. Am Heart J (1975) 0.89

The Ancillary Services Review Program in Massachusetts. Experience of the 1982 pilot project. JAMA (1984) 0.89

Impulse conduction and gap junctional remodelling by endothelin-1 in cultured neonatal rat ventricular myocytes. J Cell Mol Med (2009) 0.89

Mechanisms for impulse initiation in isolated human atrial fibers. Circ Res (1980) 0.89

Reversibility of chronic obstructive lung disease in infants following repair of ventricular septal defect. J Pediatr (1977) 0.89

Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias B. Re-entry. Section I. Am Heart J (1974) 0.88

Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A. Am Heart J (1975) 0.88

Mechanisms of action of antiarrhythmic drugs. Circ Res (1973) 0.88

Specific alpha 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ Res (1990) 0.88

Alpha and beta adrenergic effects on human atrial specialized conducting fibers. Circulation (1978) 0.88

Restorative effect of epinephrine on the electrophysiologic properties of depressed human atrial tissue. J Electrocardiol (1977) 0.88

The real thing. Circ Res (2000) 0.87

Effects of therapeutic concentrations of diphenylhydantoin on transmembrane potentials of normal and depressed Purkinje fibers. J Pharmacol Exp Ther (1976) 0.87

Cellular electrophysiologic effects of vertebrate digitalis-like substances. J Am Coll Cardiol (1988) 0.87

Effects of disopyramide on electrophysiologic properties of canine cardiac purkinje fibers. J Pharmacol Exp Ther (1977) 0.87

Abnormal cardiac repolarization and impulse initiation in German shepherd dogs with inherited ventricular arrhythmias and sudden death. Cardiovasc Res (1999) 0.87

Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human atria. Circulation (1976) 0.86